Executive Director, Quantitative Pharmacology and Pharmacometrics

Merck Merck · Pharma · PA

Executive Director, Quantitative Pharmacology and Pharmacometrics (QP2) role at Merck, focusing on the immunology pipeline. The role involves leading a team of QP2 scientists, providing scientific and operational oversight, and driving model-informed decision-making throughout the drug discovery and development process. Key responsibilities include developing translational strategies, understanding the global regulatory landscape for drug submissions, and collaborating with cross-functional teams. Requires a Ph.D./PharmD with significant experience in pharmaceutical drug development and regulatory affairs, specifically within immunology.

What you'd actually do

  1. Leading a team of up to 7 QP2 scientists including people management, scientific and operational oversight, under the direction of the Therapeutic Area Head of Immunology
  2. Leveraging end-to-end drug discovery/development and disease area expertise to independently provide day-to-day scientific oversight to individual contributors
  3. Maintaining a comprehensive understanding of global regulatory expectations for all relevant modalities, shaping the clinical pharmacology regulatory strategy for selected immunology assets, and ensuring high quality regulatory documents (INDs, CSRs, CTDs)
  4. Applies immunology knowledge and strategic thinking to identify, prioritize and develop enabling modeling platforms (disease, mechanistic, comparator models) at scale to create a differentiated immunology portfolio in an end-to-end manner in partnership with key internal/external collaborators
  5. Implements quantitative clinical pharmacology, pharmacometrics and translational modeling efforts to streamline drug discovery and development strategies and integrating knowledge to inform key decisions

Skills

Required

  • Clinical Pharmacology
  • Immunology
  • Informed Decision Making
  • People Management
  • Pharmacometrics
  • Regulatory Submissions
  • Stakeholder Relationship Management
  • Strategic Planning
  • Educational background in biopharmaceutics, pharmaceutical sciences, pharmacometrics, chemical/biomedical engineering, computational biology, or a related field
  • Immunology therapeutic area and translational science knowledge
  • Demonstrated experience in regulatory strategies in Immunology including prior experience independently authoring and defending regulatory filings for marketing authorization (NDA/MAA)
  • Extensive experience in developing quantitative strategies for impacting pipeline decisions across different phases, and including complex modalities
  • Strong understanding of functional deliverables in drug R&D, with an ability to connect QP2 contributions to broader activities and needs
  • Demonstrated ability to lead interdisciplinary teams or taskforces, and to oversee and drive results through the work of others
  • Record of ability to operate in an inclusive and high-performance work environment applying enterprise ways of working principles including fostering collaboration and driving results, while managing ambiguity
  • Proficiency in written and verbal communication, interdisciplinary collaboration, and problem scoping and planning

Nice to have

  • Expert skills in performing mechanistic modeling and/or population PK/PKPD analyses using standard software (e.g., Mathlab, NONMEM, R, Monolix, Phoenix, etc.)
  • Scientific understanding of biopharmaceutical and ADME properties across modalities
  • Record of applying mechanistic models to inform decisions
  • Recognized leader in the field of quantitative pharmacology with a track record of sustained external visibility through publications, presentations and/or involvement in professional organizations

What the JD emphasized

  • regulatory landscape
  • regulatory submissions
  • regulatory filings
  • regulatory strategy
  • regulatory documents
  • regulatory expectations